| Date Filed | Type | Description |
| 05/12/2023 |
4
| CROSKREY STEPHEN (CEO & Chairman of the Board) has filed a Form 4 on Danimer Scientific, Inc.|
Txns:
| Granted 39,333 shares
@ $0 |
|
| 03/31/2023 |
4/A
| CROSKREY STEPHEN (CEO & Chairman of the Board) has filed a Form 4 on Danimer Scientific, Inc.|
Txns:
| Granted 750,000 options
@ $2.58, valued at
$1.9M
Granted 300,000 options
@ $7.5, valued at
$2.3M
Granted 385,000 options to buy
@ $0 |
|
| 03/02/2023 |
4
| CROSKREY STEPHEN (CEO & Chairman of the Board) has filed a Form 4 on Danimer Scientific, Inc.|
Txns:
| Granted 1,305,970 options
@ $2.58, valued at
$3.4M
Granted 678,295 options to buy
@ $0 |
|
| 02/09/2023 |
5
| CROSKREY STEPHEN (CEO & Chairman of the Board) has filed a Form 5 on Danimer Scientific, Inc. |
| 04/04/2022 |
4
| CROSKREY STEPHEN (CEO and Chairman of the Board) has filed a Form 4 on Danimer Scientific, Inc.|
Txns:
| Granted 439,698 options to buy
@ $0 |
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| CROSKREY STEPHEN (CEO and Chairman of the Board) has filed a Form 4 on Danimer Scientific, Inc.|
Txns:
| Paid exercise price by delivering 98,968 shares
@ $8.2, valued at
$811.5k
|
|
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |